Skip to content

Obsessive Compulsive Treatment Efficacy Trial (OCTET)

Obsessive Compulsive Treatment Efficacy Trial (OCTET)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN73535163
Enrollment
432
Registered
2011-04-05
Start date
2012-02-01
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive compulsive disorder Mental and Behavioural Disorders Obsessive compulsive disorder

Interventions

1. Computer-aided cognitive based therapy (cCBT) package (OC Fighter) over 12 weeks 2. Supported by six, 10-minute brief scheduled telephone calls, face to face or email contact (depen

Sponsors

University of Manchester (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Current inclusion criteria as of 17/09/2014: 1. Adults aged 18 and above meeting Diagnostic and Statistical Manual of Mental Disorders (DSM) IV criteria for obsessive compulsive disorder (assessed using six OCD questions from the Mini-International Neuropsychiatric Interview [M.I.N.I.]) 2. Scoring 16 or over on the Yale Brown Obsessive Compulsive Checklist (YBOCS) 3. On a waiting list for therapist-led cognitive behavioral therapy (CBT) in either primary or secondary mental health care settings 4. Able to read English at a level of 11 years and above Previous inclusion criteria: 1. Adults aged 18 and above meeting Diagnostic and Statistical Manual of Mental Disorders (DSM) IV criteria for obsessive compulsive disorder (assessed using the Structured Clinical Interview for DSM-IV [SCID-IV]) 2. Scoring 16 or over on the Yale Brown Obsessive Compulsive Checklist (YBOCS) 3. On a waiting list for therapist-led cognitive behavioral therapy (CBT) in either primary or secondary mental health care settings 4. Able to read English at a level of 11 years and above

Exclusion criteria

Exclusion criteria: Current exclusion criteria as of 17/09/2014: 1. Participants who are actively suicidal 2. Patients with organic brain disease 3. Those who are experiencing psychosis 4. Those who have a diagnosis (DSM IV) criteria of drug or alcohol misuse 5. Patients who are currently receiving a psychological treatment for OCD 6. Those who have literacy or language difficulties to an extent which would preclude them from reading written or web-based materials or conversing with a health professional Previous exclusion criteria: 1. Participants who are actively suicidal 2. Patients with organic brain disease 3. Those who are experiencing psychosis 4. Those who have a diagnosis (DSM IV) criteria of drug or alcohol misuse 5. Patients who are currently receiving a psychological treatment for OCD 6. Patients who have received CBT for OCD in the last 6 months 7. Those who have literacy or language difficulties to an extent which would preclude them from reading written or web-based materials or conversing with a health professional 8. Patients who have been prescribed or changed to an alternative anti-depressant in the 12 weeks prior to assessment will be excluded. These patients will be offered a further assessment following 12 weeks of stable medication if there are no plans to increase the medication

Design outcomes

Primary

MeasureTime frame
Yale-Brown Obsessive Compulsive Scale (Y BOCS) checklist

Secondary

MeasureTime frame
1. Self-reported health-related quality of life (SF-36) 2. Self-reported OCD symptoms (YBOCs self-rated) 3. Generic mental health (CORE-OM) 4. Depression (PHQ9) 5. Anxiety (GAD-7) 6. Functioning (WSA) 7. Health-related quality of life (EQ5D) 8. Employment status (IAPT Employment Status questions A13 ?A15) 9. Patient satisfaction (CSQ) and acceptability (qualitative interviews) 10. Percentage of patients not improved or partially improved requiring more intensive CBT Added 17/09/2014: 11. Adult Service Use Schedule (AD-SUS) ? self complete and interview

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 20, 2026